Protein O-Fucosyltransferase 2 Is Not Essential for Plasmodium berghei Development

dc.contributor.authorSanz Sender, Silvia
dc.contributor.authorAquilini, Eleonora
dc.contributor.authorTweedell, Rebecca E.
dc.contributor.authorVerma, Garima
dc.contributor.authorHamerly, Timothy
dc.contributor.authorHritzo, Bernadette
dc.contributor.authorTripathi, Abhai
dc.contributor.authorMachado, Marta
dc.contributor.authorChurcher, Thomas S.
dc.contributor.authorRodrigues, Joao A.
dc.contributor.authorIzquierdo Lázaro, Luis
dc.contributor.authorDinglasan, Rhoel R.
dc.date.accessioned2019-09-02T10:57:43Z
dc.date.available2019-09-02T10:57:43Z
dc.date.issued2019-07-03
dc.date.updated2019-08-02T18:00:58Z
dc.description.abstractThrombospondin type I repeat (TSR) domains are commonly O-fucosylated by protein O-fucosyltransferase 2 (PoFUT2), and this modification is required for optimal folding and secretion of TSR-containing proteins. The human malaria parasite Plasmodium falciparum expresses proteins containing TSR domains, such as the thrombospondin-related anonymous protein (TRAP) and circumsporozoite surface protein (CSP), which are O-fucosylated. TRAP and CSP are present on the surface of sporozoites and play essential roles in mosquito and human host invasion processes during the transmission stages. Here, we have generated PoFUT2 null-mutant P. falciparum and Plasmodium berghei (rodent) malaria parasites and, by phenotyping them throughout their complete life cycle, we show that PoFUT2 disruption does not affect the growth through the mosquito stages for both species. However, contrary to what has been described previously by others, P. berghei PoFUT2 null mutant sporozoites showed no deleterious motility phenotypes and successfully established blood stage infection in mice. This unexpected result indicates that the importance of O-fucosylation of TSR domains may differ between human and RODENT malaria parasites; complicating our understanding of glycosylation modifications in malaria biology.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2235-2988
dc.identifier.pmid31334132
dc.identifier.urihttps://hdl.handle.net/2445/138989
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3389/fcimb.2019.00238
dc.relation.ispartofFrontiers in Cellular and Infection Microbiology, 2019, vol. 9
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/608295/EU//GLYCOPAR
dc.relation.urihttp://dx.doi.org/10.3389/fcimb.2019.00238
dc.rightscc by (c) Sanz et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationPlasmodium falciparum
dc.subject.classificationMalària
dc.subject.otherMalaria
dc.titleProtein O-Fucosyltransferase 2 Is Not Essential for Plasmodium berghei Development
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
SanzS_Front_Cell_Infect_Microbiol_2019.pdf
Mida:
724.18 KB
Format:
Adobe Portable Document Format